Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY – Get Free Report) was the target of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 100 shares, a decrease of 50.0% from the October 31st total of 200 shares. Based on an average trading volume of 700 shares, the short-interest ratio is currently 0.1 days.
Aspen Pharmacare Stock Performance
Shares of Aspen Pharmacare stock opened at $9.33 on Friday. Aspen Pharmacare has a 52 week low of $9.17 and a 52 week high of $13.69. The stock has a 50 day moving average price of $10.35 and a two-hundred day moving average price of $11.72. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.81 and a quick ratio of 1.07.
Aspen Pharmacare Cuts Dividend
The firm also recently declared a dividend, which was paid on Tuesday, October 8th. Investors of record on Friday, September 20th were given a $0.1202 dividend. The ex-dividend date was Friday, September 20th.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- What is the Australian Securities Exchange (ASX)
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- What is the NASDAQ Stock Exchange?
- 3 Penny Stocks Ready to Break Out in 2025
- How to Calculate Inflation Rate
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.